|
1
|
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.
|
Lancet Neurol
|
2007
|
3.47
|
|
2
|
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.
|
Ann Neurol
|
2005
|
3.45
|
|
3
|
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain.
|
Ann Neurol
|
2004
|
3.23
|
|
4
|
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
|
Lancet Neurol
|
2012
|
3.15
|
|
5
|
Diffusion tensor imaging of post mortem multiple sclerosis brain.
|
Neuroimage
|
2006
|
2.35
|
|
6
|
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography.
|
Brain
|
2007
|
2.18
|
|
7
|
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.
|
Lancet Neurol
|
2010
|
2.03
|
|
8
|
Gray matter atrophy is related to long-term disability in multiple sclerosis.
|
Ann Neurol
|
2008
|
1.91
|
|
9
|
Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.
|
Radiology
|
2009
|
1.66
|
|
10
|
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain.
|
J Magn Reson Imaging
|
2007
|
1.54
|
|
11
|
A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
|
Brain
|
2010
|
1.48
|
|
12
|
A serial MRI study following optic nerve mean area in acute optic neuritis.
|
Brain
|
2004
|
1.32
|
|
13
|
Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum.
|
Neuroimage
|
2006
|
1.20
|
|
14
|
White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus.
|
Neuroimage
|
2007
|
1.18
|
|
15
|
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.
|
Trials
|
2011
|
1.09
|
|
16
|
Adaptive cortical plasticity in higher visual areas after acute optic neuritis.
|
Ann Neurol
|
2005
|
1.05
|
|
17
|
Early factors associated with axonal loss after optic neuritis.
|
Ann Neurol
|
2011
|
1.02
|
|
18
|
Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study.
|
J Neurol
|
2004
|
0.99
|
|
19
|
Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.
|
Arch Neurol
|
2008
|
0.96
|
|
20
|
Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis.
|
Mult Scler
|
2010
|
0.94
|
|
21
|
Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
|
J Magn Reson Imaging
|
2013
|
0.93
|
|
22
|
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis.
|
Biol Psychiatry
|
2010
|
0.92
|
|
23
|
Principal component and linear discriminant analysis of T1 histograms of white and grey matter in multiple sclerosis.
|
Magn Reson Imaging
|
2006
|
0.90
|
|
24
|
A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis.
|
J Neurol
|
2007
|
0.88
|
|
25
|
Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.
|
Mult Scler
|
2004
|
0.83
|
|
26
|
Scanning laser polarimetry quantification of retinal nerve fiber layer thinning following optic neuritis.
|
J Neuroophthalmol
|
2010
|
0.82
|
|
27
|
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
|
Hum Brain Mapp
|
2012
|
0.80
|
|
28
|
TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
|
Mult Scler
|
2010
|
0.79
|
|
29
|
Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas.
|
J Magn Reson Imaging
|
2007
|
0.76
|
|
30
|
Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
|
J Negat Results Biomed
|
2004
|
0.75
|
|
31
|
ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.
|
Mult Scler
|
2012
|
0.75
|